# AVAVA, Inc.

> AVAVA, Inc. is a Waltham, Massachusetts medical aesthetics company that builds energy-based laser platforms for skin renewal that work across all skin tones. Spun out of Boston-based Blossom Innovations and rooted in research from Massachusetts General Hospital's Wellman Center for Photomedicine, AVAVA's flagship MIRIA Skin Treatment System pairs patented Focal Point Technology with AI-driven skin visualization to deliver precise, high-energy intradermal treatment for conditions like melasma, hyperpigmentation, and acne scars with minimal downtime.

- **Founded:** 2017
- **Headquarters:** Waltham, Massachusetts, United States
- **Founders:** Irina Erenburg (Founder, CEO & President), R. Rox Anderson (Co-inventor / Scientific Founder), Dieter Manstein (Co-inventor / Scientific Founder), Henry H.L. Chan (Co-inventor / Scientific Founder)
- **Team size:** ~67 employees
- **Products:** MIRIA Skin Treatment System, Focal Point Technology, ComfortCool, MyAVAVA, AVAVASyncPro
- **Notable:** FDA 510(k) clearance for the MIRIA Skin Treatment System for prevention and treatment of skin aging, FDA 510(k) clearance to treat benign pigmented lesions including hyperpigmentation (2022), FDA clearance for treating acne scars across all Fitzpatrick skin types (I-VI)

## Products & services

- **MIRIA Skin Treatment System** — FDA-cleared, first-in-class high-energy skin renewal laser platform using patented Focal Point Technology to deliver energy at any skin depth with precision, treating skin aging, benign pigmented lesions, hyperpigmentation, melasma and acne scars across all Fitzpatrick skin types.
- **Focal Point Technology** — Patented precision energy-delivery method that focuses laser energy intradermally at a chosen depth, more than doubling the usable therapeutic dose while protecting surrounding tissue and darker skin tones.
- **ComfortCool** — Integrated skin-cooling system that enhances patient comfort and protects surrounding tissue during treatment.
- **MyAVAVA** — Patient engagement platform for tracking and personalizing the treatment journey.
- **AVAVASyncPro** — Provider-facing management and workflow platform with AI-driven skin visualization for planning and monitoring treatments.

## Achievements

- FDA 510(k) clearance for the MIRIA Skin Treatment System for prevention and treatment of skin aging
- FDA 510(k) clearance to treat benign pigmented lesions including hyperpigmentation (2022)
- FDA clearance for treating acne scars across all Fitzpatrick skin types (I-VI)
- NewBeauty Award 2025 - Best Multitasking Laser and Best Innovation
- Clinical validation published in the Journal of the American Academy of Dermatology (JAAD)
- Raised $35 million in 2024 to fund commercial expansion

## Latest updates

- **2025** — MIRIA wins NewBeauty Award for Best Multitasking Laser and Best Innovation.
- **2025** — FDA clearance for acne scar treatment across all Fitzpatrick skin types.
- **2024-06** — Secured $35 million in financing (Series C plus $10M growth capital from Catalio) to support commercial expansion.
- **2022-08** — Received FDA 510(k) clearance to treat benign pigmented lesions including hyperpigmentation.

## Links

- Website: https://avavaskin.com
- LinkedIn: http://www.linkedin.com/company/avavaaskin
- Instagram: https://www.instagram.com/avavaskin/
- Facebook: https://www.facebook.com/AVAVAskin/

---

Profile page: https://yespress.io/avava-inc
Published by YesPress — https://yespress.io
Last updated: 2026-07-22